All In MedTech

FDA Clearance Tracker · P200045-S002

RelayPro Thoracic Stent-Graft System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 7, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 7, 2023

Approved

Time to decision

295 days

Received May 16, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P200045-S002
Device name
RelayPro Thoracic Stent-Graft System
Applicant location
Sunrise, FL
Received
May 16, 2022
Decided
Mar 7, 2023
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200045

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval of the RelayPro Thoracic Stent Graft System for treatment of all lesions of the descending thoracic aorta. The RelayPro Thoracic Stent-Graft System is indicated for the endovascular repair of all lesions of the descending thoracic aorta in patients having appropriate anatomy, including:1) Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;2) Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) or proximal and distal landing zones with diameters between 19 to 42 mm (traumatic aortic injuries);3) Non-aneurysmal proximal aortic neck lengths (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) or landing zones (traumatic aortic injuries) of: a. 15 mm for the 22 to 28 mm device diameters (Bare Stent Configuration) b. 20 mm for the 30 to 38 mm device diameters (Bare Stent Configuration) c. 25 mm for the 40 to 46 mm device diameters (Bare Stent Configuration) d. 25 mm for the 22 to 38 mm device diameters (Non-Bare Stent Configuration) e. 30 mm for the 40 to 46 mm device diameters (Non-Bare Stent Configuration)4) Non-aneurysmal distal aortic neck lengths (fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers) of: a. 25 mm for the 24 to 38 mm device diameters b. 30 mm for the 40 to 46 mm device diameters5) Non-aneurysmal distal landing zone of 20 mm for traumatic aortic injuries (22 to 46mm device diameters) and dissections (24 to 46mm device diameters)The RelayPro Thoracic Stent-Graft System (NBS configuration) is indicated for the endovascular distal extension of the Thoraflex Hybrid device.

Source documents

Other decisions for Bolton Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.